1. Home
  2. CORT vs IONQ Comparison

CORT vs IONQ Comparison

Compare CORT & IONQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CORT
  • IONQ
  • Stock Information
  • Founded
  • CORT 1998
  • IONQ 2015
  • Country
  • CORT United States
  • IONQ United States
  • Employees
  • CORT N/A
  • IONQ N/A
  • Industry
  • CORT Biotechnology: Pharmaceutical Preparations
  • IONQ Wholesale Distributors
  • Sector
  • CORT Health Care
  • IONQ Industrials
  • Exchange
  • CORT Nasdaq
  • IONQ Nasdaq
  • Market Cap
  • CORT 7.5B
  • IONQ 8.5B
  • IPO Year
  • CORT N/A
  • IONQ N/A
  • Fundamental
  • Price
  • CORT $69.15
  • IONQ $42.35
  • Analyst Decision
  • CORT Strong Buy
  • IONQ Strong Buy
  • Analyst Count
  • CORT 4
  • IONQ 7
  • Target Price
  • CORT $142.00
  • IONQ $41.43
  • AVG Volume (30 Days)
  • CORT 856.9K
  • IONQ 21.1M
  • Earning Date
  • CORT 08-05-2025
  • IONQ 08-06-2025
  • Dividend Yield
  • CORT N/A
  • IONQ N/A
  • EPS Growth
  • CORT 8.36
  • IONQ N/A
  • EPS
  • CORT 1.14
  • IONQ N/A
  • Revenue
  • CORT $685,446,000.00
  • IONQ $43,057,000.00
  • Revenue This Year
  • CORT $35.85
  • IONQ $102.99
  • Revenue Next Year
  • CORT $35.22
  • IONQ $95.74
  • P/E Ratio
  • CORT $60.53
  • IONQ N/A
  • Revenue Growth
  • CORT 30.93
  • IONQ 69.92
  • 52 Week Low
  • CORT $32.33
  • IONQ $6.22
  • 52 Week High
  • CORT $117.33
  • IONQ $54.74
  • Technical
  • Relative Strength Index (RSI)
  • CORT 45.05
  • IONQ 49.65
  • Support Level
  • CORT $67.44
  • IONQ $41.29
  • Resistance Level
  • CORT $73.78
  • IONQ $44.64
  • Average True Range (ATR)
  • CORT 2.08
  • IONQ 2.51
  • MACD
  • CORT -0.31
  • IONQ -0.37
  • Stochastic Oscillator
  • CORT 26.97
  • IONQ 21.86

About CORT Corcept Therapeutics Incorporated

Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol. The company's compounds are being evaluated in clinical trials as potential treatments for a variety of serious disorders - hypercortisolism, advanced ovarian cancer, prostate cancer, ALS, and MASH.

About IONQ IonQ Inc.

IonQ Inc sells access to several quantum computers of various qubit capacities and is in the process of researching and developing technologies for quantum computers with increasing computational capabilities. The company currently makes access to its quantum computers available via cloud platforms and also to select customers via its own cloud service. This cloud-based approach enables the broad availability of quantum-computing-as-a-service (QCaaS). The company derives its revenue from its quantum-computing-as-a-service arrangements, consulting services related to co-developing algorithms on company's quantum computing systems, and contracts associated with the design, development, and construction of specialized quantum computing systems together with related services.

Share on Social Networks: